Lebel B, Bousquet J, Morel A, Chanal I, Godard P, Michel F B
INSERM U58, Montpellier, France.
J Allergy Clin Immunol. 1988 Nov;82(5 Pt 1):869-77. doi: 10.1016/0091-6749(88)90092-9.
Nasal challenges with pollen grains represent one of the techniques of provocation. However, the clinical criteria of positivity are not clearly established. Nasal challenges with increasing numbers of orchard-grass pollen grains were performed in 60 patients allergic to grass pollens and 20 normal subjects. Before any challenge, the nose was washed three times with saline and then lactose, and 50, 150, 450, 1350, and 4050 orchard-grass pollen grains were insufflated into the nostrils until a symptom score of 5 was reached. This score was mainly based on major symptoms of allergic rhinitis, for example, rhinorrhea, nasal obstruction, sneezes, and to a lesser extent, on minor symptoms, such as pruritus, conjunctivitis, and pharyngitis. Nasal secretions were obtained after each challenge by lavage. Histamine was titrated by a radioimmunoassay with a monoclonal antibody against acylated histamine. Prostaglandin D2 (PGD2) was assayed with an enzyme immunoassay with a polyclonal antibody against PGD2 methoxamine. None of the normal subjects had a symptom score greater than 2; 55/60 patients had a positive challenge. The release of PGD2 was significantly (p less than 0.001, Kruskal-Wallis test) correlated with a symptom score of 5; 74.5% of patients had a significant release of PGD2 in nasal secretions. In contrast, although 58.2% of patients had a release of histamine in nasal secretions when the challenge was positive, the correlation with symptom scores was not significant. PGD2 in nasal secretions increased 3.7-fold after a positive nasal challenge.(ABSTRACT TRUNCATED AT 250 WORDS)
用花粉颗粒进行鼻腔激发试验是激发技术之一。然而,阳性的临床标准尚未明确确立。对60名对草花粉过敏的患者和20名正常受试者进行了递增数量果园草花粉颗粒的鼻腔激发试验。在每次激发试验前,先用盐水冲洗鼻腔三次,然后用乳糖冲洗,将50、150、450、1350和4050个果园草花粉颗粒吹入鼻孔,直至症状评分为5分。该评分主要基于过敏性鼻炎的主要症状,如流涕、鼻塞、打喷嚏,在较小程度上基于次要症状,如瘙痒、结膜炎和咽炎。每次激发试验后通过灌洗获取鼻分泌物。用抗酰化组胺单克隆抗体的放射免疫分析法滴定组胺。用抗PGD2甲氧胺多克隆抗体的酶免疫分析法测定前列腺素D2(PGD2)。没有一名正常受试者的症状评分大于2;60名患者中有55名激发试验呈阳性。PGD2的释放与症状评分为5显著相关(p<0.001,Kruskal-Wallis检验);74.5%的患者鼻分泌物中PGD2有显著释放。相比之下,尽管激发试验呈阳性时58.2%的患者鼻分泌物中有组胺释放,但与症状评分的相关性不显著。鼻腔激发试验阳性后,鼻分泌物中的PGD2增加了3.7倍。(摘要截短于250字)